Serum Concentrations of TIM-3, LAG-3, and PD-1 in Patients with Hemorrhagic Fever with Renal Syndrome

被引:0
|
作者
Safranko, Zeljka Macak [1 ]
Jakopec, Lana [1 ]
Svagusa, Karla [1 ]
Krajinovic, Lidija Cvetko [1 ]
Tomasovic, Domagoj [1 ]
Lukic, Ljiljana [1 ]
Markotic, Alemka [1 ,2 ,3 ]
机构
[1] Univ Hosp Infect Dis Dr Fran Mihaljev, Res Unit, Zagreb 10000, Croatia
[2] Univ Rijeka, Fac Med, Rijeka 51000, Croatia
[3] Catholic Univ Croatia, Fac Med, Zagreb 10000, Croatia
来源
LIFE-BASEL | 2024年 / 14卷 / 05期
关键词
orthohantavirus; HFRS; PUUV; inhibitory receptors; immune regulations; TIM-3; LAG-3; PD-1; T-CELL EXHAUSTION; INHIBITORY RECEPTORS; EXPRESSION; VIRUS; PROTEIN; HANTAVIRUSES; ACTIVATION; MACROPHAGE; AUTOIMMUNE; RESPONSES;
D O I
10.3390/life14050551
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Hemorrhagic fever with renal syndrome (HFRS) is a rodent-borne disease widespread in Europe and Asia. HFRS is caused by negative-sensed single-stranded RNA orthohantaviruses transmitted to humans through inhaling aerosolized excreta of infected rodents. Symptoms of HFRS include acute kidney injury, thrombocytopenia, hemorrhages, and hypotension. The immune response raised against viral antigens plays an important role in the pathogenesis of HFRS. Inhibitory co-receptors are essential in regulating immune responses, mitigating immunopathogenesis, and reducing tissue damage. Our research showed an increased soluble form of inhibitory co-receptors TIM-3, LAG-3, and PD-1 in HFRS patients associated with disease severity. Our study aimed to investigate the impact of HFRS on the concentrations of soluble forms of inhibitory receptors TIM-3, LAG-3, and PD-1 in the patient's serum and the potential correlation with key clinical parameters. Our study aimed to investigate the impact of HFRS on the concentrations of soluble forms of inhibitory receptors TIM-3, LAG-3, and PD-1 in the patient's serum and their possible association with relevant clinical parameters. Using multiplex immunoassay, we found elevated levels of TIM-3, LAG-3, and PD-1 proteins in the serum of HFRS patients. Furthermore, increased levels were associated with creatinine, urea, lactate dehydrogenase concentrations, and platelet count. These findings suggest that these proteins play a role in regulating the immune response and disease progression.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] PD-1 says goodbye, TIM-3 says hello
    Diana Romero
    Nature Reviews Clinical Oncology, 2016, 13 : 203 - 203
  • [32] Simultaneous inhibition of PD-1 and LAG-3: the future of immunotherapy?
    Abi-Aad, Sasha-Jane
    Zouein, Joseph
    Chartouni, Antoine
    Naim, Nabih
    Kourie, Hampig Raphael
    IMMUNOTHERAPY, 2023, 15 (08) : 611 - 618
  • [33] Immune Co-inhibitory Receptors PD-1, CTLA-4, TIM-3, LAG-3, and TIGIT in Medullary Thyroid Cancers: A Large Cohort Study
    Shi, Xiao
    Li, Cui-Wei
    Tan, Li-Cheng
    Wen, Shi-Shuai
    Liao, Tian
    Zhang, Yan
    Chen, Tong-Zhen
    Ma, Ben
    Yu, Peng-Cheng
    Lu, Zhong-Wu
    Qu, Ning
    Wang, Yu
    Shi, Rong-Liang
    Wang, Yu-Long
    Ji, Qing-Hai
    Wei, Wen-Jun
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (01): : 120 - 132
  • [34] Roles and correlations of TIM-3 and LAG-3 with cytokines and chemokines in alcoholic liver disease
    Fadriquela, Ailyn
    Kim, Cheol-Su
    Lee, Jong-Han
    CLINICA CHIMICA ACTA, 2023, 541
  • [35] LAG-3 COMPENSATES TIM-3 DOWN-REGULATION IN A HUMAN GLIOBLASTOMA MODEL
    Ogando-Rivas, Elizabeth
    Castillo-Caro, Paul
    Jones, Noah
    Dechkovskaia, Anjelika
    Yang, Changlin
    Mitchell, Duane
    NEURO-ONCOLOGY, 2020, 22 : 111 - 111
  • [36] Expression of the Immune Checkpoint Regulators LAG-3 and TIM-3 in Classical Hodgkin Lymphoma
    El Halabi, Layal
    Adam, Julien
    Gravelle, Pauline
    Marty, Virginie
    Danu, Alina
    Lazarovici, Julien
    Ribrag, Vincent
    Bosq, Jacques
    Camara-Clayette, Valerie
    Laurent, Camille
    Ghez, David
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (04): : 257 - +
  • [37] EXPRESSION AND CORRELATION OF PD-1 AND TIM-3 IN PATIENTS WITH ORAL SQUAMOUS CELL CARCINOMA
    Li, Liping
    Li, Lihong
    Lin, Wu
    ACTA MEDICA MEDITERRANEA, 2021, 37 (02): : 1069 - 1074
  • [38] Immune Co-inhibitory Receptors CTLA-4, PD-1, TIGIT, LAG-3, and TIM-3 in Upper Tract Urothelial Carcinomas: A Large Cohort Study
    Jin, Shengming
    Shang, Zhi
    Wang, Wenwen
    Gu, Chengyuan
    Wei, Yu
    Zhu, Yu
    Yang, Chen
    Zhang, Tiantian
    Zhu, Yao
    Zhu, Yiping
    Wu, Junlong
    Ye, Dingwei
    JOURNAL OF IMMUNOTHERAPY, 2023, 46 (04) : 154 - 159
  • [39] IMMUNOTHERAPY PD-1 says goodbye, TIM-3 says hello
    Romero, Diana
    NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (04) : 203 - 203
  • [40] PD-1 and LAG-3: synergistic fostering of T cell exhaustion
    Hofmann, Maike
    Thimme, Robert
    Schamel, Wolfgang W.
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2024, 9 (01)